Lund, Sweden-based MIP Technologies AB, a developer of molecularly imprinted polymers for analytical, preparative and process-scale separations, has supplied an undisclosed multi-national corporation with MIP material for solid-phase extraction at the kilogram level. Typically, MIPs are produced at the gram level by the majority of users in the R&D community.
According to the firm, molecular imprinting, a polymer nanotechnology, makes possible the creation of artificial receptor sites within stable polymer materials allowing the provision of innovative solutions for the separations market. The market covers a wide range of activities, from analytical solid phase extraction products through to large-scale solutions for selective extraction on an industrial scale.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze